{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:10:46Z","timestamp":1791223846162,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T00:00:00Z","timestamp":1389916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11910-013-0429-1","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T09:27:37Z","timestamp":1389864457000},"source":"Crossref","is-referenced-by-count":8,"title":["Recent Advances in Myotonic Dystrophy Type 2"],"prefix":"10.1007","volume":"14","author":[{"given":"Christina M.","family":"Ulane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Teed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinda","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,17]]},"reference":[{"issue":"5531","key":"429_CR1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293(5531):864\u20137.","journal-title":"Science"},{"issue":"3","key":"429_CR2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.410350305","volume":"35","author":"CA Thornton","year":"1994","unstructured":"Thornton CA, Griggs RC, Moxley 3rd RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol. 1994;35(3):269\u201372.","journal-title":"Ann Neurol"},{"issue":"1","key":"429_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.1995.00540250029009","volume":"52","author":"K Ricker","year":"1995","unstructured":"Ricker K et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol. 1995;52(1):25\u201331.","journal-title":"Arch Neurol"},{"issue":"5","key":"429_CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.410360526","volume":"36","author":"LP Rowland","year":"1994","unstructured":"Rowland LP. Thornton-Griggs-Moxley disease: myotonic dystrophy type 2. Ann Neurol. 1994;36(5):803\u20134.","journal-title":"Ann Neurol"},{"issue":"1","key":"429_CR5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1212\/WNL.52.1.170","volume":"52","author":"K Ricker","year":"1999","unstructured":"Ricker K et al. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology. 1999;52(1):170\u20131.","journal-title":"Neurology"},{"issue":"7","key":"429_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ejhg.2011.23","volume":"19","author":"T Suominen","year":"2011","unstructured":"Suominen T et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011;19(7):776\u201382.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"429_CR7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11910-002-0074-6","volume":"2","author":"LP Ranum","year":"2002","unstructured":"Ranum LP, Day JW. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr Neurol Neurosci Rep. 2002;2(5):465\u201370.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"429_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","volume":"60","author":"JW Day","year":"2003","unstructured":"Day JW et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003;60(4):657\u201364.","journal-title":"Neurology"},{"issue":"10","key":"429_CR9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00415-013-6993-0","volume":"260","author":"JE Hilbert","year":"2013","unstructured":"Hilbert JE et al. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013;260(10):2497\u2013504.","journal-title":"J Neurol"},{"issue":"3","key":"429_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/jhg.2011.152","volume":"57","author":"T Matsuura","year":"2012","unstructured":"Matsuura T et al. Myotonic dystrophy type 2 is rare in the Japanese population. J Hum Genet. 2012;57(3):219\u201320.","journal-title":"J Hum Genet"},{"issue":"12","key":"429_CR11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ejhg.2012.108","volume":"20","author":"EJ Kamsteeg","year":"2012","unstructured":"Kamsteeg EJ et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet. 2012;20(12):1203\u20138.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"429_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","volume":"56","author":"E Fournier","year":"2004","unstructured":"Fournier E et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol. 2004;56(5):650\u201361.","journal-title":"Ann Neurol"},{"key":"429_CR13","doi-asserted-by":"crossref","unstructured":"Gawel M et al. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 AND DM2). Muscle Nerve. 2013. doi: 10.1002\/mus.23908 .","DOI":"10.1002\/mus.23908"},{"issue":"3","key":"429_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1751-7133.2011.00265.x","volume":"18","author":"TM Lee","year":"2012","unstructured":"Lee TM et al. Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9. Congest Heart Fail. 2012;18(3):183\u20136.","journal-title":"Congest Heart Fail"},{"issue":"2","key":"429_CR15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","volume":"168","author":"VA Sansone","year":"2013","unstructured":"Sansone VA et al. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): Long-term outcomes. Int J Cardiol. 2013;168(2):1147\u201353.","journal-title":"Int J Cardiol"},{"issue":"10","key":"429_CR16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1540-8159.2012.03351.x","volume":"35","author":"AH Ha","year":"2012","unstructured":"Ha AH et al. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II. Pacing Clin Electrophysiol. 2012;35(10):1262\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"429_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/mus.20156","volume":"30","author":"C Schneider-Gold","year":"2004","unstructured":"Schneider-Gold C et al. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve. 2004;30(5):636\u201344.","journal-title":"Muscle Nerve"},{"issue":"4","key":"429_CR18","first-page":"324","volume":"53","author":"K Spengos","year":"2012","unstructured":"Spengos K et al. Delayed contrast enhancement on cardiac MRI unmasks subclinical cardiomyopathy in a case of myotonic dystrophy type 2. Hellenic J Cardiol. 2012;53(4):324\u20136.","journal-title":"Hellenic J Cardiol"},{"issue":"10","key":"429_CR19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.hrthm.2012.06.032","volume":"9","author":"EB Turkbey","year":"2012","unstructured":"Turkbey EB et al. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm. 2012;9(10):1691\u20137.","journal-title":"Heart Rhythm"},{"key":"429_CR20","doi-asserted-by":"crossref","unstructured":"Romigi A et al. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires. Eur J Neurol. 2013. doi: 10.1111\/ene.12226 .","DOI":"10.1111\/ene.12226"},{"issue":"6","key":"429_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000342895","volume":"68","author":"P Shepard","year":"2012","unstructured":"Shepard P et al. Sleep disturbances in myotonic dystrophy type 2. Eur Neurol. 2012;68(6):377\u201380.","journal-title":"Eur Neurol"},{"issue":"2","key":"429_CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.0b013e31829a340f","volume":"81","author":"EM Lam","year":"2013","unstructured":"Lam EM et al. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2013;81(2):157\u201364.","journal-title":"Neurology"},{"issue":"9","key":"429_CR23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.sleep.2012.07.001","volume":"13","author":"S Bhat","year":"2012","unstructured":"Bhat S et al. Sleep disordered breathing and other sleep dysfunction in myotonic dystrophy type 2. Sleep Med. 2012;13(9):1207\u20138.","journal-title":"Sleep Med"},{"issue":"4","key":"429_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11547-010-0531-2","volume":"115","author":"R Stramare","year":"2010","unstructured":"Stramare R et al. MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med. 2010;115(4):585\u201399.","journal-title":"Radiol Med"},{"issue":"6","key":"429_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-006-0111-5","volume":"253","author":"C Kornblum","year":"2006","unstructured":"Kornblum C et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol. 2006;253(6):753\u201361.","journal-title":"J Neurol"},{"issue":"6","key":"429_CR26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2012.01.006","volume":"22","author":"AA Tieleman","year":"2012","unstructured":"Tieleman AA et al. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study. Neuromuscul Disord. 2012;22(6):492\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"429_CR27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","volume":"13","author":"G Meola","year":"2003","unstructured":"Meola G et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2). Neuromuscul Disord. 2003;13(10):813\u201321.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"429_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2012.01.003","volume":"22","author":"DT Franc","year":"2012","unstructured":"Franc DT et al. Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord. 2012;22(6):483\u201391.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"429_CR29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.22249","volume":"45","author":"KI Suokas","year":"2012","unstructured":"Suokas KI et al. Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve. 2012;45(1):70\u20134.","journal-title":"Muscle Nerve"},{"issue":"4","key":"429_CR30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/hmg\/ddr515","volume":"21","author":"JD Rhodes","year":"2012","unstructured":"Rhodes JD et al. Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts. Hum Mol Genet. 2012;21(4):852\u201362.","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"429_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2013.06.008","volume":"331","author":"E Passeri","year":"2013","unstructured":"Passeri E et al. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. J Neurol Sci. 2013;331(1\u20132):132\u20135.","journal-title":"J Neurol Sci"},{"issue":"6","key":"429_CR32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.49.6.1646","volume":"49","author":"J Mathieu","year":"1997","unstructured":"Mathieu J et al. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology. 1997;49(6):1646\u201350.","journal-title":"Neurology"},{"issue":"9","key":"429_CR33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/pan.12120","volume":"23","author":"F Veyckemans","year":"2013","unstructured":"Veyckemans F, Scholtes JL. Myotonic dystrophies type 1 and 2: anesthetic care. Paediatr Anaesth. 2013;23(9):794\u2013803.","journal-title":"Paediatr Anaesth"},{"issue":"2","key":"429_CR34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mayocp.2011.09.005","volume":"87","author":"AK Win","year":"2012","unstructured":"Win AK et al. Increased cancer risks in myotonic dystrophy. Mayo Clin Proc. 2012;87(2):130\u20135.","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"429_CR35","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00415-012-6476-8","volume":"259","author":"M Das","year":"2012","unstructured":"Das M et al. Correlates of tumor development in patients with myotonic dystrophy. J Neurol. 2012;259(10):2161\u20136.","journal-title":"J Neurol"},{"issue":"2","key":"429_CR36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejogrb.2012.02.020","volume":"162","author":"C Awater","year":"2012","unstructured":"Awater C, Zerres K, Rudnik-Schoneborn S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):153\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"429_CR37","doi-asserted-by":"crossref","first-page":"e38379","DOI":"10.1371\/journal.pone.0038379","volume":"7","author":"T Kurosaki","year":"2012","unstructured":"Kurosaki T et al. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome. PLoS One. 2012;7(6):e38379.","journal-title":"PLoS One"},{"issue":"4","key":"429_CR38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/378566","volume":"73","author":"LL Bachinski","year":"2003","unstructured":"Bachinski LL et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy\/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet. 2003;73(4):835\u201348.","journal-title":"Am J Hum Genet"},{"key":"429_CR39","doi-asserted-by":"crossref","unstructured":"Nakamori M et al. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2013. doi: 10.1002\/ana.23992 .","DOI":"10.1002\/ana.23992"},{"issue":"1\u20132","key":"429_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11010-013-1681-z","volume":"380","author":"M Santoro","year":"2013","unstructured":"Santoro M et al. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. Mol Cell Biochem. 2013;380(1\u20132):259\u201365.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"429_CR41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nmd.2012.03.004","volume":"22","author":"Z Lukas","year":"2012","unstructured":"Lukas Z et al. Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2. Neuromuscul Disord. 2012;22(7):604\u201316.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"429_CR42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00418-012-0984-6","volume":"138","author":"M Giagnacovo","year":"2012","unstructured":"Giagnacovo M et al. Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2. Histochem Cell Biol. 2012;138(4):699\u2013707.","journal-title":"Histochem Cell Biol"},{"issue":"43","key":"429_CR43","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","volume":"104","author":"I Eisenberg","year":"2007","unstructured":"Eisenberg I et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A. 2007;104(43):17016\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"429_CR44","doi-asserted-by":"crossref","first-page":"e39732","DOI":"10.1371\/journal.pone.0039732","volume":"7","author":"S Greco","year":"2012","unstructured":"Greco S et al. Deregulated microRNAs in myotonic dystrophy type 2. PLoS One. 2012;7(6):e39732.","journal-title":"PLoS One"},{"issue":"7","key":"429_CR45","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1096\/fj.11-200337","volume":"26","author":"I Faenza","year":"2012","unstructured":"Faenza I et al. A role for PLCbeta1 in myotonic dystrophies type 1 and 2. FASEB J. 2012;26(7):3042\u20138.","journal-title":"FASEB J"},{"issue":"2","key":"429_CR46","first-page":"144","volume":"31","author":"SF Ursu","year":"2012","unstructured":"Ursu SF et al. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro. Acta Myol. 2012;31(2):144\u201353.","journal-title":"Acta Myol"},{"issue":"12","key":"429_CR47","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1212\/01.WNL.0000148482.40683.88","volume":"63","author":"J Berg","year":"2004","unstructured":"Berg J et al. Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current. Neurology. 2004;63(12):2371\u20135.","journal-title":"Neurology"},{"issue":"6","key":"429_CR48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","volume":"21","author":"ZZ Tang","year":"2012","unstructured":"Tang ZZ et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet. 2012;21(6):1312\u201324.","journal-title":"Hum Mol Genet"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0429-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-013-0429-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0429-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:28:30Z","timestamp":1559435310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-013-0429-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,17]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1007\/s11910-013-0429-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,17]]},"article-number":"429"}}